REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/12/2025
Back to search
Official data from USPTO
CELL CARE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELL CARE THERAPEUTICS
ST13
US500000086969366Class
5
Filing
86969366
Registration
6053560
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
05/13/2025
Trademark type
Word
Nice classes
5
Filing date
04/08/2016
Registration date
05/12/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2020
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/08/2016
First use in commerce
02/06/2018
Drawing code
4
Owner type
03
Owner location
Monrovia, CA
Examiner
GOLDEN, LAURA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. T. (pessoa física)
C. T. (pessoa física)
Representatives
John Davis Kearney, McWilliams & Davis, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and prevention of inflammatory and degenerative neuro-vascular diseases; Pharmaceutical preparations for the treatment of inflammatory and degenerative neuro-vascular diseases; Stem cells for medical purposes
Publications
History of USPTO decisions and trademark events.
65 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/09/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2020
ALIE
ASSIGNED TO LIE
04/06/2020
NREV
NOTICE OF REVIVAL - E-MAILED
03/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/28/2020
PETG
PETITION TO REVIVE-GRANTED
03/28/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
03/28/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2019
GNRT
NON-FINAL ACTION E-MAILED
09/13/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/13/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/09/2019
IUAF
USE AMENDMENT FILED
09/07/2019
EISU
TEAS STATEMENT OF USE RECEIVED
09/07/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/15/2019
EX5G
SOU EXTENSION 5 GRANTED
05/14/2019
EXT5
SOU EXTENSION 5 FILED
05/09/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/23/2018
EX4G
SOU EXTENSION 4 GRANTED
11/21/2018
EXT4
SOU EXTENSION 4 FILED
11/21/2018
EEXT
SOU TEAS EXTENSION RECEIVED
11/21/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/14/2018
EX3G
SOU EXTENSION 3 GRANTED
08/13/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/13/2018
NREV
NOTICE OF REVIVAL - E-MAILED
07/08/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
07/06/2018
PETG
PETITION TO REVIVE-GRANTED
07/06/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
07/06/2018
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
06/25/2018
ABN6
ABANDONMENT - NO USE STATEMENT FILED
06/25/2018
EXT3
SOU EXTENSION 3 FILED
05/22/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/14/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/14/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/22/2017
EX2G
SOU EXTENSION 2 GRANTED
11/20/2017
EXT2
SOU EXTENSION 2 FILED
11/20/2017
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/23/2017
EX1G
SOU EXTENSION 1 GRANTED
05/19/2017
EXT1
SOU EXTENSION 1 FILED
05/19/2017
EEXT
SOU TEAS EXTENSION RECEIVED
05/19/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/22/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/27/2016
PUBO
PUBLISHED FOR OPPOSITION
09/27/2016
DOCK
ASSIGNED TO EXAMINER
09/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/30/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/29/2016
GNRT
NON-FINAL ACTION E-MAILED
07/29/2016
CNRT
NON-FINAL ACTION WRITTEN
07/29/2016
DOCK
ASSIGNED TO EXAMINER
07/23/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/14/2016
NWAP
NEW APPLICATION ENTERED
04/12/2016
Continuous trademark protection
Get notified about every new filing that threatens CELL CARE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.